Insider · CIK 0001827180
Richard A. Zordani Jr.
Files at GALT (GALECTIN THERAPEUTICS INC). First filing Dec 26, 2024, latest Dec 26, 2024.
Richard A. Zordani Jr. files SEC Form 4 as director at GALT (GALECTIN THERAPEUTICS INC). Since Dec 26, 2024, Richard A. Zordani Jr. has reported 1 open-market buy worth $8,164 and 0 open-market sells worth $0, the latest filed on Dec 26, 2024.
A track record needs three past buys with six months of prices behind them; Richard A. Zordani Jr. has 0, so none is measured yet.
The newest scored trade: bought $8,164 of GALT on Dec 24, 2024, filed Dec 26, 2024, scored 36 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GALT: GALECTIN THERAPEUTICS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | GALECTIN THERAPEUTICS INC | $8,164 10,000 shares | +31% | - |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 16, 2026 | GALT GALECTIN THERAPEUTICS INC | AGrant or award Stock option (right to buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Jan 21, 2026 |
| Jan 23, 2025 | GALT GALECTIN THERAPEUTICS INC | AGrant or award Stock Option (right to buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Jan 27, 2025 |
| Dec 24, 2024 | GALT GALECTIN THERAPEUTICS INC | POpen-market purchase Common Stock | +10,000 | $0.82 | $8,164 | 42,083 | Dec 26, 2024 |
Questions about Richard A. Zordani Jr.
Answered from the filings on this page, as of the latest one.
Is Richard A. Zordani Jr. buying or selling?
Not in the last 12 months. Richard A. Zordani Jr.'s latest open-market trade on SEC Form 4 was bought $8,164 of GALT on Dec 24, 2024.
How did Richard A. Zordani Jr.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Richard A. Zordani Jr. has 0.
Where does Richard A. Zordani Jr. file Form 4?
Richard A. Zordani Jr. has filed Form 4 at GALT (GALECTIN THERAPEUTICS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.